The new antibody that may be able to stay ‘one step ahead’ of coronavirus mutations
Stroke care declined globally during COVID-19 pandemic despite stroke-related COVID complications
25 March 2021FDA panel rejects Pfizer’s arthritis drug as too risky
25 March 2021The new antibody that may be able to stay ‘one step ahead’ of coronavirus mutations
A new antibody that can mount a double attack on the SARS-CoV-2 virus by binding to two different sites on the spike protein is starting human trials, leading to hopes of an antibody therapy that can maintain its effectiveness even against new variants of coronavirus.
